A detailed history of Affinity Asset Advisors, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 650,000 shares of NKTX stock, worth $1.54 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
650,000
Previous 200,000 225.0%
Holding current value
$1.54 Million
Previous $1.18 Million 148.48%
% of portfolio
0.51%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.52 - $8.0 $2.03 Million - $3.6 Million
450,000 Added 225.0%
650,000 $2.94 Million
Q2 2024

Aug 14, 2024

BUY
$5.27 - $10.82 $1.05 Million - $2.16 Million
200,000 New
200,000 $1.18 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $115M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.